These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 113022)

  • 1. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of ethyl cinepazate maleate on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Mercuro G; Lai C
    Boll Soc Ital Cardiol; 1978; 23(1):265-80. PubMed ID: 113021
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial of labetalol in effort angina pectoris].
    Broustet JP; Cherrier JF; Pic A
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):171-6. PubMed ID: 4004091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of verapamil on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):248-64. PubMed ID: 754777
    [No Abstract]   [Full Text] [Related]  

  • 6. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF; White DA
    S Afr Med J; 1983 Jan; 63(3):67-71. PubMed ID: 6849167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral labetalol in the management of stable angina pectoris in normotensive patients.
    Upward JW; Akhras F; Jackson G
    Br Heart J; 1985 Jan; 53(1):53-7. PubMed ID: 3917674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
    Jee LD; Opie LH
    Am J Cardiol; 1985 Sep; 56(8):551-4. PubMed ID: 3929584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
    Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
    Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
    Puri VK; Agarwal SK; Mehrotra A; Hasan M
    Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
    Halprin S; Frishman W; Kirschner M; Strom J
    Am Heart J; 1980 Mar; 99(3):388-96. PubMed ID: 7355700
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of combined alpha- and beta-adrenoceptor blockade in angina pectoris.
    Mulac KD
    Postgrad Med J; 1983; 59 Suppl 3():33-4. PubMed ID: 6647207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
    Opie LH; White D; Lee J; Lubbe WF
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):115S-122S. PubMed ID: 7093094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J; Rasmussen S
    Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.